The SARS-CoV-2 virus may contribute to the damage of small blood vessels in the heart as seen in severely-ill Covid-19 patients, without infecting them, a study shows.
The research, published in the journal Clinical Science, indicates blocking antibodies could represent a new treatment to alleviate cardiovascular complications.
A multidisciplinary research team led by the University of Bristol, UK, analysed how SARS-CoV-2 interacts with heart cells causing the myocardial damage...read more